NCT04368897View on ClinicalTrials.gov

In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

May 1, 2020

Primary Completion Date

December 1, 2022

Study Completion Date

December 1, 2022

Conditions
SARS-CoV 2COVIDCOVID-19Androgenetic AlopeciaAndrogen Receptor AbnormalAndrogen Deficiency
Interventions
DIAGNOSTIC_TEST

CAG length <22

CAG repeat length in exon 1 of AR gene

DIAGNOSTIC_TEST

CAG length >=22

CAG repeat length in exon 1 of AR gene

Trial Locations (1)

Unknown

Hospital Universitario Ramon y Cajal, Madrid

Sponsors
All Listed Sponsors
collaborator

Hospital Universitario Ramon y Cajal

OTHER

lead

Applied Biology, Inc.

INDUSTRY

NCT04368897 - In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity | Biotech Hunter | Biotech Hunter